Hyperion DeFi, Inc. (HYPD)
NASDAQ: HYPD · Real-Time Price · USD
3.060
+0.100 (3.38%)
At close: Jun 26, 2026, 4:00 PM EDT
3.000
-0.060 (-1.96%)
After-hours: Jun 26, 2026, 7:27 PM EDT
Company Description
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid.
It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem.
It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products.
The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025.
Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.
Hyperion DeFi, Inc.
| Country | United States |
| Founded | 2014 |
| IPO Date | Jan 25, 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 9 |
| CEO | Hyunsu Jung |
Contact Details
Address: 3090 Nowitzki Way, Suite 300 Dallas, Texas 75219 United States | |
| Phone | 833 393 6684 |
| Website | hyperiondefi.com |
Stock Details
| Ticker Symbol | HYPD |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001682639 |
| CUSIP Number | 30234E104 |
| ISIN Number | US30234E2037 |
| Employer ID | 47-1178401 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hyunsu Jung | Chief Executive Officer, Chief Investment Officer and Director |
| David Knox C.F.A. | Chief Financial Officer and Treasurer |
| Robert Rubenstein | General Counsel and Secretary |
| Jason Assad | Investor Contact |
| Alexander Lobo | Investor Contact |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 5, 2026 | 8-K | Current Report |
| May 15, 2026 | 10-Q | Quarterly Report |
| May 14, 2026 | 8-K | Current Report |
| May 6, 2026 | 8-K | Current Report |
| May 6, 2026 | 424B5 | Filing |
| May 5, 2026 | ARS | Filing |
| May 5, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 5, 2026 | DEF 14A | Other definitive proxy statements |
| May 5, 2026 | 424B5 | Filing |
| Apr 17, 2026 | PRE 14A | Other preliminary proxy statements |